Drug
Bifidobacterium infantis
Bifidobacterium infantis is a pharmaceutical drug with 6 clinical trials. Historical success rate of 83.3%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
83.3%
Based on 5 completed trials
Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_2
2
33%
Ph not_applicable
2
33%
Ph phase_4
1
17%
Ph phase_1
1
17%
Phase Distribution
1
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
83.3%
5 of 6 finished
Non-Completion Rate
16.7%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(5)
Terminated(1)
Detailed Status
Completed5
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 41 (16.7%)
N/A2 (33.3%)
Trials by Status
terminated117%
completed583%
Recent Activity
0 active trials
Showing 5 of 6
completednot_applicable
Probiotics and Multi-Drug Resistant Urinary Tract Infection
NCT03644966
completedphase_2
Pilot of a Prebiotic and Probiotic Trial in Young Infants With Severe Acute Malnutrition
NCT03666572
completedphase_4
Irritable Bowel Syndrome Evaluation and Treatment in Primary Care
NCT01641341
terminatedphase_2
The Safety and Effectiveness of Probiotic Supplementation on Bipolar Depression
NCT02155972
completedphase_1
The Impact of Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Premature Infants
NCT00810160
Clinical Trials (6)
Showing 6 of 6 trials
NCT03644966Not Applicable
Probiotics and Multi-Drug Resistant Urinary Tract Infection
NCT03666572Phase 2
Pilot of a Prebiotic and Probiotic Trial in Young Infants With Severe Acute Malnutrition
NCT01641341Phase 4
Irritable Bowel Syndrome Evaluation and Treatment in Primary Care
NCT02155972Phase 2
The Safety and Effectiveness of Probiotic Supplementation on Bipolar Depression
NCT00810160Phase 1
The Impact of Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Premature Infants
NCT01018472Not Applicable
Probiotics in Infants With Cyanotic Congenital Heart Disease
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6